These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 4992010)

  • 41. [Therapeutic findings in 23 geriatric cases treated with hydergine (clinical note)].
    Tessler D
    Hospital (Rio J); 1970 Jul; 78(1):267-70. PubMed ID: 4991827
    [No Abstract]   [Full Text] [Related]  

  • 42. [Vergebro-basilar insufficiency. Prevention of transient ischemic accidents with hydergine].
    Augustin P; Lechevalier B
    Therapeutique; 1970 May; 46(5):543-6. PubMed ID: 4988090
    [No Abstract]   [Full Text] [Related]  

  • 43. [Double blind test of hydergine in the aged].
    Bargheon J
    Nouv Presse Med; 1973 Sep; 2(31):2053-5. PubMed ID: 4199834
    [No Abstract]   [Full Text] [Related]  

  • 44. [Electroencephalographic and clinical study of the action of hydrogen derivatives of Ergotoxin].
    Borenstein P; Cujo P; Bahon L
    Ann Med Psychol (Paris); 1969 Oct; 2(3):410-24. PubMed ID: 4983442
    [No Abstract]   [Full Text] [Related]  

  • 45. [Changes of the cerebral circulation time influenced by hydergine].
    Herzfeld U; Wittgen M
    Arztl Forsch; 1971 Jul; 25(7):224-30. PubMed ID: 4998670
    [No Abstract]   [Full Text] [Related]  

  • 46. [Use of peripheral vasodilator drug in peripheral and cerebrovascular syndromes of old age].
    Andalò L; Missana M
    Clin Ter; 1975 Sep; 74(5):471-84. PubMed ID: 819202
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effect of raubasine and dihydroergocristine on arteriosclerotic and hypertensive cerebral diseases].
    Klein K
    Vasa; 1973; 2(4):409-14. PubMed ID: 4202492
    [No Abstract]   [Full Text] [Related]  

  • 48. [Treatment of mental manifestations of chronic cerebral circulatory insufficiency. Clinical and psychometric study].
    Lefebvre P; Crocq L; Bernard JG
    Sem Hop; 1969 Jan; 45(5):312-7. PubMed ID: 4307724
    [No Abstract]   [Full Text] [Related]  

  • 49. [Results of treatment with SEN DCS-1. Preliminary note on 24 patients].
    Pastor Franco A
    Rev Clin Esp; 1970 Aug; 118(4):359-64. PubMed ID: 4991986
    [No Abstract]   [Full Text] [Related]  

  • 50. [Interpretation of the clinical signs in the light of recent acquisitions].
    Heyck H
    Minerva Med; 1968 Dec; 59(96):5200-6. PubMed ID: 4974812
    [No Abstract]   [Full Text] [Related]  

  • 51. [Hydergine in the treatment of chronic psychoses].
    Bohard F; Guennoc A; Klein H; Le Borgne Y; Masanes P
    Ann Med Psychol (Paris); 1967 Mar; 125(3):438-46. PubMed ID: 4964710
    [No Abstract]   [Full Text] [Related]  

  • 52. [CLINICAL STUDY ON AN ERGOT DERIVATIVE: HYDERGINE].
    REBECCHI M; GOTTI A; BENEDETTI L
    Gazz Int Med Chir; 1964 Jan; 68():207-11. PubMed ID: 14154380
    [No Abstract]   [Full Text] [Related]  

  • 53. Sinus bradycardia following treatment with hydergine for cerebrovascular insufficiency.
    Dcayley AC; Macpherson A; Wedgwood J
    Br Med J; 1975 Nov; 4(5993):384-5. PubMed ID: 811310
    [No Abstract]   [Full Text] [Related]  

  • 54. Treatment of aged psychotic patients with hydergine.
    Freeman H; Murray P
    Gerontol Clin (Basel); 1966; 8(5):279-84. PubMed ID: 4960136
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical syndromes of cerebrovascular insufficiency caused by stenosis of the cervical arteries].
    Catalano L; Tatarelli R
    Ann Med Nav (Roma); 1970; 75(5):565-74. PubMed ID: 5511879
    [No Abstract]   [Full Text] [Related]  

  • 56. [Trial of eutergine in chronic cerebral arteriopathies].
    Pauchant M; Bernard JM
    Lille Med; 1972 May; 17():Suppl 4:819-23. PubMed ID: 4626797
    [No Abstract]   [Full Text] [Related]  

  • 57. [Treatment of cerebral vascular diseases due to softening].
    Tomaselli R; Elia C
    Omnia Med Ther; 1968; 46(3):657-70. PubMed ID: 4989937
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effect of drugs on cerebrovascular circulation with special regard to Hydergin].
    Radielović P
    Lijec Vjesn; 1971; 93(11):1227-32. PubMed ID: 5005614
    [No Abstract]   [Full Text] [Related]  

  • 59. Combined hydergin and pantesin therapy of acute apoplexies, its sequelae, and diffuse sclerotic encephalopathies.
    Boganelli I; Scardigli G; Memeo SA
    G Gerontol; 1966 Dec; 14(12):1163-8. PubMed ID: 4966652
    [No Abstract]   [Full Text] [Related]  

  • 60. [Attempt at psychometric evaluation of aging: study of a vascular drug].
    Losson M; Losson JP
    Therapeutique; 1969 Mar; 45(3):313-7. PubMed ID: 4989246
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.